Atossa Genetics +55% after adopting poison pill provision

• Atossa Genetics (NASDAQ:ATOS +55.4%) surged today, apparently from this morning's announcement of a shareholder rights agreement - however, there haven't been any reports indicating the company has been the subject of takeover interest.
• The developer of breast health solutions said the agreement is designed to deter "coercive, unfair, or inadequate takeovers and other abusive tactics."